Intravenous Infusions (XGHA:IIL) Shares Buyback Ratio %: 0.00 (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Intravenous Infusions Shares Buyback Ratio %?

Intravenous Infusions XGHA:IIL +7.14% Shares Buyback Ratio % is 0.00 as of Aug. 26, 2026.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Intravenous Infusions's current shares buyback ratio was 0.00%.

Intravenous Infusions Shares Buyback Ratio % Related Terms

Intravenous Infusions Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Shares Buyback Ratio % Chart

Intravenous Infusions Annual Data
Trend
Shares Buyback Ratio %

Intravenous Infusions Semi-Annual Data
Shares Buyback Ratio %

Intravenous Infusions Shares Buyback Ratio % Calculation

Intravenous Infusions's Shares Buyback Ratio for the fiscal year that ended in . 20 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: . 20 ) - Shares Outstanding (EOP) (A: . 20 )) / Shares Outstanding (EOP) (A: . 20 )
=( - ) /
=N/A%

Intravenous Infusions's Shares Buyback Ratio for the quarter that ended in . 20 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: . 20 ) - Shares Outstanding (EOP) (A: . 20 )) / Shares Outstanding (EOP) (A: . 20 )
=( - ) /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of 0.00 mean?
Intravenous Infusions (XGHA:IIL) has a Shares Buyback Ratio % of 0.00 as of Aug. 26, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Intravenous Infusions and its competitors.
Is Intravenous Infusions' Shares Buyback Ratio % too high?
Intravenous Infusions' current Shares Buyback Ratio % is 0.00.
How does Intravenous Infusions' Shares Buyback Ratio % compare to PTLF and PCYN?
Intravenous Infusions' Shares Buyback Ratio % of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Drug Manufacturers company?
A good Shares Buyback Ratio % depends on the Drug Manufacturers industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Intravenous Infusions and its competitors. Intravenous Infusions's current Shares Buyback Ratio % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current Shares Buyback Ratio % of 0.00. The current Shares Buyback Ratio % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current Shares Buyback Ratio % is 0.00 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.